Pfizer selects Adams & Knight to solidify Viagra brand in Africa and Middle East Markets

Agency expands work in pharmaceutical sector

Pfizer Inc. (NYSE:PFE), the world’s largest research-based pharmaceutical company, has selected Adams & Knight, Inc. (A&K) for consumer and professional marketing for its Viagra^® brand in the Middle East and Africa. A&K, one of Connecticut’s largest integrated marketing agencies will manage Viagra^® patient, physician, and pharmacist communications in a campaign that will include TV, print, online and point-of-sale marketing.

Reem Nouh, A&K’s SVP of strategic services and healthcare marketing and a seasoned pharmaceutical marketer, leads the account. She has lived and worked in the Middle East and is fluent in Arabic. “Viagra is seeking a solution to stand out among competitors in a market that’s overwhelmed,” said Nouh, “By developing a strategic and integrated campaign, we will be able to increase the share of voice for the Viagra^® brand in its Africa and Middle East markets.”

During her career, Nouh has managed multiple accounts for world-recognized pharmaceutical clients, including Pfizer, GSK, Novartis, Roche and Alcon. She has helped to develop patient and physician marketing campaigns for established pharmaceutical brands such as Lipitor^®, Viagra^®, Xalatan^®, Norvasc^® and Advair^®, in both the U.S. and Middle East markets.

“The campaign has been well accepted and we have received positive reviews from marketing managers all across the Middle East and Africa,” said Bill Knight, principal of Adams & Knight. “This campaign called for a fully integrated approach from our team including design products, interactive and traditional marketing. We are pleased to be working with such a distinguished and global client.”